These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28949940)

  • 21. Radium 223: how can we optimize this new tool for metastatic castration-resistant prostate cancer?
    Dorff TB; Gross ME
    Am Soc Clin Oncol Educ Book; 2015; ():e270-3. PubMed ID: 25993185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.
    Cha TL; Wu TT; Vogelzang NJ; Huang CY; Huang SP; Lin CC; Ou YC; Pang ST; Shen DH; Wu WJ; Chang WY
    J Formos Med Assoc; 2017 Nov; 116(11):825-836. PubMed ID: 29046247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223.
    Rodriguez-Vida A; Torregrosa MD; Pinto Á; Climent MÁ; Olmos D; Carles J
    Clin Transl Oncol; 2018 Jun; 20(6):679-686. PubMed ID: 29098556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.
    Hoskin P; Sartor O; O'Sullivan JM; Johannessen DC; Helle SI; Logue J; Bottomley D; Nilsson S; Vogelzang NJ; Fang F; Wahba M; Aksnes AK; Parker C
    Lancet Oncol; 2014 Nov; 15(12):1397-406. PubMed ID: 25439694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current perspectives on bone metastases in castrate-resistant prostate cancer.
    Logothetis C; Morris MJ; Den R; Coleman RE
    Cancer Metastasis Rev; 2018 Mar; 37(1):189-196. PubMed ID: 29380085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases.
    Vogelzang NJ
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):809-819. PubMed ID: 28649893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical guide to the use of radium 223 dichloride.
    Den RB; Doyle LA; Knudsen KE
    Can J Urol; 2014 Apr; 21(2 Supp 1):70-6. PubMed ID: 24775727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer.
    Shimada T; Izumi K; Kano H; Kadomoto S; Makino T; Naito R; Iwamoto H; Yaegashi H; Kadono Y; Mizokami A
    Anticancer Res; 2022 Feb; 42(2):1065-1071. PubMed ID: 35093908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radium-223 international early access program: results from the Spanish subset.
    Carles J; Méndez MJ; Pinto Á; Sáez MI; Arranz JA; Maroto P; López-Criado P; Mellado B; Donas JG; Hernando S; León L; Del Alba AG; Laínez N; Esteban E; Reynés G; Pérez-Gracia JL; Germà JR; López-Brea M; Pérez-Valderrama B; Moretones C; Castellano D
    Future Oncol; 2018 Jan; 14(1):41-50. PubMed ID: 29232987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases].
    Tauber R; Gschwend J; Scheidhauer K; Eiber M; Krönke M
    Urologe A; 2017 Jan; 56(1):24-31. PubMed ID: 28058455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223.
    Odo U; Vasudevamurthy AK; Sartor O
    Clin Genitourin Cancer; 2017 Jun; 15(3):e501-e502. PubMed ID: 28111175
    [No Abstract]   [Full Text] [Related]  

  • 32. Radium-223 mechanism of action: implications for use in treatment combinations.
    Morris MJ; Corey E; Guise TA; Gulley JL; Kevin Kelly W; Quinn DI; Scholz A; Sgouros G
    Nat Rev Urol; 2019 Dec; 16(12):745-756. PubMed ID: 31712765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosing, administration, and safety of radium-223: How I do it.
    Dan TD; Doyle L; Raval AJ; Pridjian A; Gomella LG; Den RB
    Can J Urol; 2016 Jun; 23(3):8301-5. PubMed ID: 27347625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radium-223 in the treatment of bone metastasis in patients with castration-resistant prostate cancer. Review and procedure.
    Orcajo-Rincon J; Caresia-Aróztegui AP; Del Puig Cózar-Santiago M; García-Garzón JR; de Arcocha-Torres M; Delgado-Bolton RC; García-Velloso MJ; Alvarez-Ruiz S; García-Vicente AM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(5):330-337. PubMed ID: 29661653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer.
    Jadvar H; Challa S; Quinn DI; Conti PS
    Cancer Biother Radiopharm; 2015 Jun; 30(5):195-9. PubMed ID: 25746633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer.
    Borsò E; Boni G; Galli L; Ricci S; Farnesi A; Mazzarri S; Cianci C; Mariani G; Falcone A
    Future Oncol; 2015; 11(2):323-31. PubMed ID: 25075962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer.
    Buroni FE; Persico MG; Pasi F; Lodola L; Nano R; Aprile C
    Anticancer Res; 2016 Nov; 36(11):5719-5730. PubMed ID: 27793893
    [No Abstract]   [Full Text] [Related]  

  • 38. The timing of radium-223 therapy in castration-resistant prostate cancer.
    Sartor O
    Clin Adv Hematol Oncol; 2015 Sep; 13(9):570-2. PubMed ID: 26452186
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
    Taneja SS
    J Urol; 2015 Mar; 193(3):847-8. PubMed ID: 25765385
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives.
    van der Doelen MJ; Mehra N; Hermsen R; Janssen MJR; Gerritsen WR; van Oort IM
    Clin Genitourin Cancer; 2019 Apr; 17(2):79-87. PubMed ID: 30558834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.